Concepedia

Markus Letsch

ML

Statistics

Publications

7

Citations

229

H-Index

7

Active since

2002

Affiliations

Tulane University(Current)

Tulane Medical Center

Veterans Health Administration

Markus Letsch is an author at Tulane University specializing in medicine, molecular oncology, and hormonal cancer therapy.

Publications per year

2002–2006

7

Publications

7

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers

Markus Letsch, Andrew V. Schally, Rebeca Busto et al. · Proceedings of the National Academy of Sciences · 2003 · 72 citations · Full text

, , +14

Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.

Markus Letsch, Andrew V. Schally, Károly Szepesházi et al. · PubMed · 2003 · 44 citations · Full text

, , +17

Inhibition of proliferation of PC‐3 human prostate cancer by antagonists of growth hormone–releasing hormone: Lack of correlation with the levels of serum IGF‐I and expression of tumoral IGF‐II and vascular endothelial growth factor

Artur Płonowski, Andrew V. Schally, Markus Letsch et al. · The Prostate · 2002 · 34 citations

, , +17

Targeted chemotherapy with cytotoxic bombesin analogue AN‐215 inhibits growth of experimental human prostate cancers

Anton Stangelberger, Andrew V. Schally, Markus Letsch et al. · International Journal of Cancer · 2005 · 26 citations · Full text

, , +13

Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities

Márta Zarándi, József L. Varga, Andrew V. Schally et al. · Proceedings of the National Academy of Sciences · 2006 · 22 citations · Full text

, , +14

1–5 of 7